Ciencias de la Salud
Campo de conocimiento
![Foto de Ciencias de la Salud](/img/noimage.png)
![Foto de Hospital Sierrallana](/img/noimage_org.png)
Hospital Sierrallana
Torrelavega, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Sierrallana (97)
2024
-
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort
Lupus Science and Medicine, Vol. 11, Núm. 1
-
Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients
RMD open, Vol. 10, Núm. 2
2023
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry
Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2811-2823
2022
-
Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
Seminars in Arthritis and Rheumatism, Vol. 52
-
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients
Seminars in Arthritis and Rheumatism, Vol. 55
-
Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients
Clinical and Experimental Rheumatology
-
Statin use and 30-day mortality in patients with acute symptomatic pulmonary embolism
Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 8, pp. 1839-1851
2021
-
Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge
British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1269-1278
-
Body mass index and disease activity in chronic inflammatory rheumatic diseases: Results of the cardiovascular in rheumatology (CARMA) project
Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-10
-
Clinical and preclinical evidence of somatosensory involvement in amyotrophic lateral sclerosis
British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1257-1268
-
Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
Clinical and Experimental Rheumatology, Vol. 39, Núm. 3, pp. 555-563
-
European registry on helicobacter pylori management: Effectiveness of first and second-line treatment in Spain
Antibiotics, Vol. 10, Núm. 1, pp. 1-15
-
Timing and characteristics of venous thromboembolism after noncancer surgery
Journal of Vascular Surgery: Venous and Lymphatic Disorders, Vol. 9, Núm. 4, pp. 859-867.e2
-
Treatment with tofacitinib in refractory psoriatic arthritis: A national multicenter study of the first 87 patients in clinical practice
Journal of Rheumatology, Vol. 48, Núm. 10, pp. 1552-1558
2020
-
A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 21, Núm. 3-4, pp. 252-262
-
ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage
Journal of Neurology, Vol. 267, Núm. 5, pp. 1291-1299
-
Anti-il-6 receptor tocilizumab in refractory graves’ orbitopathy: National multicenter observational study of 48 patients
Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-15
-
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
Lupus, Vol. 29, Núm. 12, pp. 1556-1565
-
Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients
Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 1, pp. 89-98